ACW.AX - Actinogen Medical Limited

ASX - ASX Delayed price. Currency in AUD
Currency in AUD

Valuation measures4

Market cap (intra-day) 111.99M
Enterprise value 97.63M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)6.97
Enterprise value/revenue N/A
Enterprise value/EBITDA -9.11

Trading information

Stock price history

Beta (5Y monthly) 2.07
52-week change 3-32.88%
S&P500 52-week change 31.77%
52-week high 30.1600
52-week low 30.0400
50-day moving average 30.0632
200-day moving average 30.0873

Share statistics

Avg vol (3-month) 3653.82k
Avg vol (10-day) 31.12M
Shares outstanding 51.81B
Implied shares outstanding 6N/A
Float 81.27B
% held by insiders 119.57%
% held by institutions 114.94%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:2
Last split date 303 Dec 2013

Financial highlights

Fiscal year

Fiscal year ends 30 June 2022
Most-recent quarter (mrq)31 Dec 2022


Profit margin -239.90%
Operating margin (ttm)-241.44%

Management effectiveness

Return on assets (ttm)-32.24%
Return on equity (ttm)-54.82%

Income statement

Revenue (ttm)4.64M
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)3,732.80%
Gross profit (ttm)3.64M
EBITDA -10.89M
Net income avi to common (ttm)-11.14M
Diluted EPS (ttm)-0.0100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.48M
Total cash per share (mrq)0.01
Total debt (mrq)126.75k
Total debt/equity (mrq)0.79
Current ratio (mrq)8.85
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-8.58M
Levered free cash flow (ttm)-4.54M